ADORA2A and Parkinson disease: We then tested if this increased synaptic ATP release in the presymptomatic phase would drive a bolstered CD73-mediated A2AR modulation of corticostriatal synaptic plasticity in presymptomatic PD, as occurs in early AD [10] or shortly after convulsions [30].